MedPath

AMOREPACIFIC CORPORATION

🇰🇷South Korea
Ownership
-
Established
2006-01-01
Employees
-
Market Cap
-
Website
http://eng.amorepacific.co.kr/

Clinical Trials

23

Active:0
Completed:21

Trial Phases

4 Phases

Phase 1:4
Phase 2:7
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials

Not Applicable
11 (47.8%)
Phase 2
7 (30.4%)
Phase 1
4 (17.4%)
Phase 3
1 (4.3%)

Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex

Not Applicable
Recruiting
Conditions
Body Fat
First Posted Date
2024-09-24
Last Posted Date
2024-09-24
Lead Sponsor
Amorepacific Corporation
Target Recruit Count
100
Registration Number
NCT06609603
Locations
🇰🇷

Catholic University St. Vincent Hospital, Suwon, Gyeonggi-do, Korea, Republic of

Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation

Not Applicable
Recruiting
Conditions
Blood Sugar
First Posted Date
2024-09-12
Last Posted Date
2024-09-12
Lead Sponsor
Amorepacific Corporation
Target Recruit Count
84
Registration Number
NCT06592365
Locations
🇰🇷

Kangbuk samsung hospital, Seoul, Korea, Republic of

🇰🇷

Seoul National Universtiy Hospital, Seoul, Korea, Republic of

🇰🇷

The Catholic University of Korea St. Vincent's Hospital, Seoul, Korea, Republic of

Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1

Not Applicable
Completed
Conditions
Body Fat
First Posted Date
2024-05-20
Last Posted Date
2024-05-22
Lead Sponsor
Amorepacific Corporation
Target Recruit Count
100
Registration Number
NCT06422013
Locations
🇰🇷

Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of

Evaluated the Efficacy and Safety of APCP on Hair Health

Not Applicable
Completed
Conditions
Hair Damage
First Posted Date
2024-05-20
Last Posted Date
2024-05-22
Lead Sponsor
Amorepacific Corporation
Target Recruit Count
150
Registration Number
NCT06422026
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue.

Not Applicable
Completed
Conditions
Fatigue
First Posted Date
2023-02-13
Last Posted Date
2023-05-26
Lead Sponsor
Amorepacific Corporation
Target Recruit Count
88
Registration Number
NCT05725044
Locations
🇰🇷

Inha University Hospital, Incheon, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath